Cck B (Cckbr) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons expressing cholecystokinin B receptor (CCKBR), the major CCK receptor in the brain. CCKBR (also known as CCK-B or CCK2) is a G protein-coupled receptor (GPCR) belonging to the gastrin/cholecystokinin receptor family. In the brain, CCKBR is widely distributed and plays crucial roles in modulating anxiety, memory, pain perception, and appetite. CCKBR neurons represent a significant population of GABAergic interneurons in cortical and hippocampal regions, where they regulate neuronal excitability and circuit-level processing.
[^2]
[^3]
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | CL:0002277 | type I enteroendocrine cell |
| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | CL:0002277 | type I enteroendocrine cell | Exact |
CCKBR-expressing neurons are found throughout the central nervous system with particularly high densities in:
- Hippocampus: CA1 and CA3 pyramidal layers, dentate gyrus hilus. CCKBR is highly expressed on basket cells and other GABAergic interneurons targeting pyramidal neuron somata.
- Cerebral Cortex: Layers II-III and V-VI, particularly in prefrontal, entorhinal, and piriform cortices.
- Amygdala: Central nucleus, basolateral complex, especially in intercalated cell masses.
- Hypothalamus: Paraventricular nucleus, suprachiasmatic nucleus, arcuate nucleus.
- Midbrain: Periaqueductal gray, dorsal raphe nucleus, substantia nigra pars compacta.
- Brainstem: Nucleus tractus solitarius, dorsal motor nucleus of the vagus.
The distribution pattern suggests CCKBR neurons play modulatory roles in limbic circuits, autonomic processing, and sensory integration.
CCKBR is a 447-amino acid GPCR that couples primarily to Gq/11 proteins, activating phospholipase C (PLC) signaling cascades:
- Ligands: Cholecystokinin (CCK-4, CCK-8, CCK-33), gastrin (at lower affinity)
- Signaling: PLCβ → IP3/DAG → Ca²⁺ mobilization and PKC activation
- Expression: CCKBR mRNA peaks during early development (P7-P14) and remains stable in adulthood
- Alternative splicing: Produces splice variants with altered G-protein coupling efficiency
- Dimerization: Can form homodimers and heterodimers with CCK-A receptors
CCKBR neurons exhibit distinct electrophysiological signatures:
- Resting membrane potential: -65 to -75 mV
- Input resistance: 150-300 MΩ (varies by brain region)
- Action potential duration: 0.8-1.5 ms
- Firing patterns: Predominantly fast-spiking and non-adapting in cortical regions
- Synaptic inputs: Dense excitatory input from pyramidal neurons; receives inhibitory input from other interneurons
- Synaptic outputs: Powerful perisomatic inhibition onto pyramidal neurons via GABA release
CCKBR neurons form inhibitory connections within local circuits:
- Cortical microcircuitry: CCKBR basket cells target pyramidal neuron somata and proximal dendrites
- Hippocampal circuitry: Mossy fiber-associated CCK cells modulate CA3 pyramidal neuron activity
- Amygdala networks: CCKBR interneurons in basolateral amygdala regulate fear circuitry
- Long-range projections: Some CCKBR neurons project to distant targets including thalamus and brainstem
CCKBR neurons are affected in Alzheimer's disease through multiple mechanisms:
- Amyloid-β impact: Aβ1-42 reduces CCKBR expression in hippocampal interneurons, disrupting GABAergic inhibition
- Tau pathology: CCKBR neurons show early tau accumulation in the entorhinal cortex
- Network dysfunction: Loss of CCK interneuron-mediated inhibition contributes to hippocampal hyper excitability and seizure activity in AD
- Cognitive correlates: CCKBR polymorphisms are associated with age-related cognitive decline
- Therapeutic potential: CCKBR agonists show promise in improving memory consolidation in animal models
- CCKBR expression is altered in the basal ganglia of PD patients
- CCKBR neurons in the substantia nigra pars reticulata may compensate for dopaminergic degeneration
- CCK-8 administration can reduce levodopa-induced dyskinesias via CCKBR activation
¶ Anxiety and Panic Disorders
- CCKBR is a key receptor in panic and anxiety circuitry
- CCK-4 (a CCKBR agonist) induces panic attacks in humans and rodents
- CCKBR antagonists (e.g., proglumide) have anxiolytic properties
- CCKBR polymorphisms are linked to panic disorder susceptibility
- CCKBR in periaqueductal gray and spinal cord modulates nociception
- CCKBR activation produces analgesic effects in inflammatory and neuropathic pain models
- Endogenous CCK acts as a tonic pain inhibitor
CCKBR represents a therapeutic target for:
- Anxiety and panic disorder: CCKBR antagonists as anxiolytics
- Alzheimer's disease: CCKBR agonists for cognitive enhancement
- Pain management: CCKBR-targeted analgesics
- Obesity: CCKBR involvement in satiety signaling
- Epilepsy: CCKBR modulation as anticonvulsant strategy
- Localization: In situ hybridization, immunohistochemistry for CCKBR
- Functional studies: Calcium imaging, electrophysiology in acute brain slices
- Genetic models: CCKBR knockout mice show increased anxiety and impaired memory
- Optogenetics: Channelrhodopsin expression under CCK promoter for circuit mapping
The study of Cck B (Cckbr) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.